William Blair Reiterates Market Perform Rating on Palantir
- Rating
- Market Perform
- Unchanged
- Target
- N/A
- No target in this note
- Upside
- N/A
- No target to measure
The median of 19 current targets on Palantir is $250.

What the analyst said
William Blair analyst Louie DiPalma reiterated a Market Perform rating on Palantir Technologies Inc. (NASDAQ: PLTR).
“We updated our Palantir commercial logo tracker for the new customer logos that were announced and gave presentations at today’ s AIPCon 8. W e previously analyzed the new customer logos that were announced at AIPCon 7, which took place in March ( New Slate of AIPCon Customers Suggests the Commercial Momentum Has Continued; V aluation Remains Frothy ), and compared the number of logos to the prior conferences.
Contact your William Blair sales representative if you would like a copy of our tracker . OpenAI is clearly not impacting Palantir ’ s growth rate this year or even perhaps next year . W e forecast Palantir ’ s U.S. commercial business to grow 103% for the September quarter .
An overall Rule-of- 100 quarter is possible as incredible as that sounds. The question is: how long will it take for competitors to catch up? While Palantir continues to experience major momentum, some investors are concerned about how the competitive landscape evolves five years from now with OpenAI and peers rapidly raising capital, poaching talent, emulating the forward deployed engineer model, and aggressively pursuing the enterprise and defense end- markets.
On the defense side, Palantir has secured several contracts already in the September quarter. Our Dotted Line tracker is monitoring other large programs in the pipeline.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.




